Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

被引:0
|
作者
Mingchu Sun
Wenhua Jiang
Nan Mu
Zihui Zhang
Lu Yu
Heng Ma
机构
[1] Northwestern Polytechnical University,Institute of Medical Research
[2] Fourth Military Medical University,Department of Physiology and Pathophysiology, School of Basic Medical Sciences
[3] Fourth Military Medical University,Department of Pathology, Xijing Hospital
关键词
Cardiovascular diseases; Mitochondrial dysfunction; Mitochondrial transplantation; Ischemia reperfusion injury; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.
引用
收藏
相关论文
共 50 条
  • [31] Novel microRNAs as Putative Therapeutic Targets in Cardiovascular Diseases
    Karapetsas, Athanasios
    Tokamani, Maria
    Kolettas, Evangelos
    Sandaltzopoulos, Raphael
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (05) : 564 - 565
  • [32] Recent updates on novel therapeutic targets of cardiovascular diseases
    Muhammad Afzal
    Molecular and Cellular Biochemistry, 2021, 476 : 145 - 155
  • [33] Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
    Bhatti, Gurjit Kaur
    Gupta, Anshika
    Pahwa, Paras
    Khullar, Naina
    Singh, Satwinder
    Navik, Umashanker
    Kumar, Shashank
    Mastana, Sarabjit Singh
    Reddy, Arubala P.
    Reddy, P. Hemachandra
    Bhatti, Jasvinder Singh
    BIOMEDICAL JOURNAL, 2022, 45 (05) : 733 - 748
  • [34] Therapeutic mitochondrial transplantation
    McCully, James
    del Nido, Pedro J.
    Emani, Sitaram M.
    CURRENT OPINION IN PHYSIOLOGY, 2022, 27
  • [35] Indole analogs have novel therapeutic effects on mitochondrial diseases
    Matsuhashi, Tetsuro
    Suzuki, Takehiro
    Matsuo, Akihiro
    Oba, Yuuki
    Suzuki, Kousuke
    Kikuchi, Kouichi
    Shima, Hisato
    Takeuchi, Youichi
    Mishima, Eikan
    Akiyama, Yasutoshi
    Suzuki, Chitose
    Sato, Takeya
    Yanagisawa, Teruyuki
    Hayashi, Kenichiro
    Osaka, Hitoshi
    Nakada, Kazuto
    Abe, Takaaki
    MITOCHONDRION, 2016, 31 : 96 - 97
  • [36] Targeting antioxidants to mitochondria: A potential new therapeutic strategy for cardiovascular diseases
    Victor, V. M.
    Rocha, M.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (08) : 845 - 863
  • [37] Exosomes in Mesenchymal Stem Cells, a New Therapeutic Strategy for Cardiovascular Diseases?
    Huang, Lina
    Ma, Wenya
    Ma, Yidi
    Feng, Dan
    Chen, Hongyang
    Cai, Benzhi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2015, 11 (02): : 238 - 245
  • [38] Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases
    Peng, Dewei
    Wang, Aizan
    Shi, Wei
    Lin, Li
    ARCHIVES OF PHARMACAL RESEARCH, 2024, 47 (8-9) : 709 - 735
  • [39] MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases
    Zhen-wei Pan
    Yan-jie Lu
    Bao-feng Yang
    Acta Pharmacologica Sinica, 2010, 31 : 1 - 9
  • [40] The Impact of Novel Treatment Modalities on the Therapeutic Approach of Cardiovascular Diseases
    Paraskevas, Kosmas I.
    Psathas, Chrisovalantis
    Dragios, Theodoros
    Chatzis, Dimitrios G.
    Mikhailidis, Dimitri P.
    Kyriakides, Zenon S.
    ANGIOLOGY, 2009, 60 (01) : 5 - 7